Site Start-Up

In Site Start-Up (SSU) our team owns a large part of the critical pathway to and the coordination of all aspects of site activation before handing off to clinical operations.

SSU is one of the most complex and heavily regulated parts of any clinical trial or program launch. This includes trial & site feasibility, regulatory document collection & review, local regulatory & ethics intelligence & submissions, and site contract and budget negotiations.

Working efficiently in SSU, we help reduce the time it takes for patients to start their clinical trial journeys and help bring lifesaving treatments to those that need them.

Functional Service Provider (FSP)

An FSP relationship is a partnership between Syneos Health and a Sponsor. Every partnership is unique with each one tailored to achieve our customer’s visions and goals. This allows us to grow and evolve with our customers as their portfolio needs evolve.

For Syneos Health it means that colleagues who like structure and predictability, and who truly enjoy relationship building in the work environment, tend to thrive in FSP environments.

Sponsors look to Syneos Health for technical expertise. They expect our colleagues to be an extension of their team and to bring new ideas; demonstrate expertise in technology and processes; escalate recommendations for improvements and take opportunities to innovate. In other words, Syneos Health has a voice.

Our People

 

Maricel
Sr SSU Project Delivery Manager, SSU Project Delivery

I am proud to be part of a team that works on a common goal of driving the start-up activities in an efficient, quality-focused, and shortest timelines as possible. I am happy that every day I am part of the bigger picture of being a step closer to a new treatment.

 

Title

Location

Date Posted

Location: Argentina-Latin America - ARG-Home-Based
Date Posted: February 7, 2025
Location: United States-North America - US Home-Based
Date Posted: September 9, 2024
Location: Belgium-Europe - BEL-Home-Based
Date Posted: September 3, 2024